Mixed Response to Ipilimumab in a Melanoma Patient with Brain Metastases: Case Report and Review of the Literature

Mixed Response to Ipilimumab in a Melanoma Patient with Brain Metastases: Case Report and Review of the Literature

Management of patients suffering from metastatic malignant melanoma and brain metastasis remains challenging in routine clinical practice. The inhibitory anti-CTLA-4 antibody ipilimumab has recently been approved as second-line therapeutic option for melanoma patients. Increasing evidence suggests d...

Full description

Bibliographic Details
Main Authors: Georg Feldmann, Peter Brossart, Matthias Zipfel, Marie von Lilienfeld-Toal
Format: Article
Language:English
Published: Karger Publishers 2013-04-01
Series:Case Reports in Oncology
Subjects:
Ipilimumab
Melanoma
Brain metastases
Survival
Online Access:http://www.karger.com/Article/FullText/351125

Similar Items

Similar Items